Risk of nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid and updated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment
暂无分享,去创建一个
N. Schieda | T. McGrath | V. Nair | P. Sathiadoss | Isabelle Gauthier | Chad Arthur Macleod | Chad A. MacLeod